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Abstract
Background. Cardiovascular malformations (CVM) are one of the
most prevalent groups of birth defects. Knowledge about the preva-
lence, distribution and survival in Russia has been limited. The aim of
our study was to assess the perinatal prevalence, structure and risk
factors for CVM among newborns in Monchegorsk (Murmansk Oblast,
Russia) and the mortality among the affected newborns in the period
1973-2008. 
Design and methods. A register-based study on data from the Kola
and Murmansk County Birth Registers. The study included 28,511
births. 
Results. The registered perinatal prevalence was 3.0 per 1000 new-
borns, with septal defects as the most prevalent. CVM was twenty
times more prevalent among stillborn than live born, and one-third of
the live born with a CVM died during the first week of life. The perina-
tal mortality rate with CVM was 442 per 1000 newborns. This indicator
decreased over time. The mothers of newborns with a CVM were ten
times more likely to have stillbirth in their anamnesis. The adjusted
odds ratio between maternal smoking during pregnancy and CVM was
4.09 [95% confidence interval: 1.75-9.53].
Conclusions. The diagnosed perinatal prevalence was relatively low.
A previous stillbirth by the mother was highly associated with being
born with a CVM. An adjusted elevated risk was also observed among
smoking mothers. Perinatal survival increased over time, but varied to
a large extent between the different types of CVM.
Introduction
Cardiovascular malformations (CVM) are one of the most prevalent
groups of birth defects and include congenital heart defects and vessels
anomalies. In the populations covered by the European Surveillance of
Congenital Anomalies (EUROCAT), the total prevalence of CVM in 2000-
2005 was 7.97 per 1000 births (including stillborn and terminations of
pregnancy due to fetal anomaly).1 The reported prevalence in other
countries has varied from 3 to 12 per 1000 births.2-7
Cardiovascular malformations are considered an important public
health issue, being the main cause of infant deaths in developed coun-
tries. In the United States, CVM represented about 1/3 of all infant
deaths, which were due to congenital anomalies. On the other hand,
recent advances in medical care for this group of patients result in
increased survival into adulthood. It has been estimated that the
worldwide adult population with a CVM is growing by 5% per year.8 
Little is known about CVM prevalence in the Russian Federation
(RF). No administrative units are members of EUROCAT, and only a
register in the Moscow Oblast is a member of International
Clearinghouse for Birth Defects Surveillance and Research. According
to federal methodology, systematic registration is obligatory for only
two forms of CVM: transposition of great vessels and hypoplasia of left
heart.9 As far as northern territories of RF are concerned, sources of
information about CVM prevalence are limited, and no studies are yet
available. The Russian Institute of Public Health estimated the preva-
lence in North-West Russia to be in the range 2.7-3.8 per 1000 children
(0-13 years) in 2006-2008.10 In the population-based birth register in
Monchegorsk, which was the first of its kind in the RF, all anomalies
diagnosed prenatally were systematically registered − in contrary to
the national norm. These data provide a possibility to quantify and
analyse the perinatal prevalence and survival of newborns with CVM in
a population of northern Russia, which we have made use of in this
study.
The mortality rate in the RF from cardiovascular diseases and CVM
among children 0-14 years was 14.4 per 100,000 children in year 2000.
According to official figures of the RF, about 50% of children with CVM
die neonatally without receiving specialised medical aid, and an addi-
tional 25% die later in infancy.11
The aetiology of most CVM is not well defined. Gene mutations and
chromosomal aberrations are evident in a portion of the cases. The
heart develops in the period 3-11 weeks of gestation, and hence the
critical period for exposure to teratogens.12 Among the birth defects
observed to co-occur with chromosomal anomalies, neural tube defects
are more common than malformations of the heart. An increased risk
of CVM has been observed when maternal age is above 41 or under 16
years,13,14 and when the mother smokes, drinks alcohol or uses drugs
in early pregnancy.13,15-17 Maternal diseases, such as diabetes mellitus,
obesity and overweight, and viral infections during pregnancy (rubel-
la, Coxsackie virus, respiratory viruses) are also reported to be risk
factors.15,18,19 In addition some occupational exposures (e.g. dyes, lac-
quers or paints) appear to increase the risk.20 The aetiology of a CVM
usually involves combinations of several factors.12,13
The aim of our study was to investigate the perinatal prevalence and
structure of CVM among newborns in Monchegorsk, and the mortality
among the affected newborns. The associations between potential risk
factors during pregnancy and CVM were also assessed.
Significance for public health
Cardiovascular malformation is one of the most common groups of birth
defects. It is considered an important public health issue, as these malfor-
mations are the main cause of infant deaths in developed countries. Precise
estimates about the prevalence and perinatal survival are needed to organ-
ise and plan health care for such newborns. Our study is the first report from
the Russian Federation based on data from population-based birth registers. 
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Design and methodsContext and study population
Monchegorsk had 47,975 inhabitants in 2010 and is one of the
largest cities in Murmansk Oblast (MO) in north-west Russia
(Census-2010 official results). The main employer is the local nickel
refinery complex. The study population was all newborns in the town-
ship in the period 1973-2008, a total of 28,650 live and stillborn.
Obligatory ultrasound screening for fetal anomalies was established in
the RF from year 2000. The maternal care and maternal benefits in
Russia, as well as the study population, have been described earlier in
some detail.21,22Data sources and inclusion in the study
The study was register-based using data from the Kola Birth Register
(KBR) and Murmansk County Birth Register. The Kola (Monchegorsk) birth register 
Information about all births in Monchegorsk from March 1973
through 2005 was compiled in a population-based birth register, a total
of 26,841 births. The register was set up to study the association
between occupational exposures and reproductive health and pregnan-
cy outcome. Data about all live births and stillbirths from 28 weeks of
pregnancy were collected from general medical journals, the hospital
gynaecology records and delivery records.21 The validity of these med-
ical sources has been recognised as satisfactory for epidemiological
investigations.23 We included all registered newborns in the study,
except those for whom the source chart containing diagnoses at birth
was missing or the interpretation of the recorded diagnosis was uncer-
tain. The total number of excluded newborns was 130 (0.5%). Hence,
26,711 newborns from the years 1973-2005 were included in the study.The Murmansk County birth register  
The Murmansk County Birth Register (MCBR) includes all births in
MO since January 1st, 2006. The registered data have been systemati-
cally collected in all 15 obstetrics departments in MO from five sources:
the mother’s medical history, obstetric journal and delivery record, the
newborn’s birth record, and through an interview with the mother con-
ducted by a physician or midwife.24 In the period 2006-2008, the regis-
tered births included 1809 births in Monchegorsk. Of these, nine
records were missing data about birth defects and excluded from the
study. The population coverage of the register was estimated to 98.9%
in 2006.24 In both registries, the diagnoses of congenital malformations
were registered based on the International Classification of Disease
(ICD) coding system. According to the tenth version (ICD-10), all CVM
were coded in the range Q 20-Q 28. The diagnoses were made before
the newborns left the birth clinic. From the late 1990s the use of
echocardiography supplemented routine examinations and prenatal
indications of CVM needed confirmation by examination after birth. In
case of fetal deaths, the diagnosis was based on autopsy results. 
In total the study included 28,511 newborns. Data analysis 
To analyse the structure of CVM, the prevalence and proportional dis-
tribution of the different forms were estimated based on the registered
two- and three-digit level ICD-10 code. Newborns with more than one
CVM-diagnosis were included in the numerator for each diagnosis.
Newborns with multiple malformations were included in the numera-
tor, if CVM was present among the diagnoses. These analyses were also
carried out for stillbirths and for early neonatal deaths separately. In
addition, the stillbirth, early neonatal and perinatal mortality rates
among newborns with CVM were estimated. The time trends of the
prevalence and mortality were estimated using six 6-year time inter-
vals from 1973 to 2008, and tested using chi-square for trend (MedCalc
12.0 software). All prevalence estimates are presented with 95% confi-
dence intervals (CI). The prevalence of selected, possible risk factors
was estimated for newborns with and without CVM, respectively, and
statistically compared using the chi-square or t-test. The comparison
between the two groups was carried out for the following potential risk
factors: mean maternal age, parity, TORCH infections (i.e., toxoplasmo-
sis, rubella, cytomegalovirus, herpes simplex, syphilis) during preg-
nancy, alcohol abuse during pregnancy, tobacco smoking during preg-
nancy, endocrine disease during pregnancy, paternal or maternal
employment in the production departments of the nickel factory at the
onset of the pregnancy, maternal occupation with exposure to organic
solvents, and maternal body mass index (BMI) at the first antenatal
visit. The adjusted risk of a CVM associated with the studied risk fac-
tors was analysed by multiple logistic regression, with CVM as a bina-
ry outcome (IBM SPSS 17.0 software package). The significance level
in all analyses was set at five per cent.Ethical considerations
The data in the birth registers have been approved for research pur-
poses by the Murmansk Regional Health Administration and the
Committee for Research Ethics at the University in Tromsø.
Permission to use the register data was obtained from the KBR and
MCBR. The data files obtained for this study contained no personal
identifiers.  
Results
Of the 28,511 newborns, 436 were from multiple-birth deliveries, 274
were stillborn (1.0%), and 555 (1.9%) died during the first 7 days after
birth. The total number of newborns with one or more anomalies was
1029 (36.1 per 1000 newborns), of these 86 had one or more CVM [3.0
(95% CI: 2.1, 3.9) per 1000 newborns]. One newborn had three CVM,
three newborns had two and the rest had one CVM; one in this last
group was born as a twin. The mean gestational age for newborns with
CVM was significantly lower in comparison with the reference group.
The women who delivered a baby with a CVM were ten times more like-
ly to have had a previous stillbirth than the mothers of the newborns
without a diagnosed CVM. Maternal smoking was more prevalent in the
CVM group (P=0.03). Additional characteristics of mothers, pregnan-
cies and newborns in the study groups are presented in Table 1.  
The prevalence of CVM among stillborn was 51/1000 (95% CI:
25/1000, 78/1000), compared to 2.5/1000 (95% CI: 1.4/1000, 3.1/1000)
among live born. Sixteen per cent of the newborns with CVM were still-
born. The prevalence of CVM among term and preterm stillbirths did
not differ: 54.5/1000 (95%CI: 11.4/1000, 97.7/1000) and 49.4/1000
(95%CI: 15.7/1000, 83.1/1000). The prevalence of newborns with CVM,
and among live- and stillborn, in the different time periods is present-
ed in Table 2. The total prevalence did not change over time (χ2=0.12,
P=0.7). Of the 72 live newborns with CVM, 25 were delivered preterm
and 24 died during the first seven days (333 per 1000 live births). All
newborns with chamber defects and 86% of newborns with anomalies
in arteries and veins died perinatally. The perinatal mortality rate with
isolated CVM or combined with other congenital malformations was
442 per 1000 newborns with CVM. This indicator decreased over time
(χ2=602.01, P<0.0001). 
Table 3 shows the structure of CVM among all newborns and those
who died perinatally. Septal defects constituted 27% of all CVM and
were the most prevalent of the verified diagnoses, while among still-
born and perinatal deaths, chamber defects were the most prevalent
(24.1%). In total, 46.1% of the CVM diagnoses were unspecified, but
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this percentage was smaller among those who died perinatally. Of the
two types of CVM that have been obligatory to register in the federal
system in the RF, there was one diagnosed case (Q 20.3).
The adjusted odds ratio (OR) for smoking during pregnancy was 4.09
(95% CI: 1.75, 9.53). None of the other risk factors we studied were
associated with the risk of CVM (Table 4). 
Discussion
A relatively high average stillbirth rate (10/1000 births) with a slight
decline in the last decade was observed in Monchegorsk.  In most
European countries, it was less than 6 per 1000 newborns in the same
period.25 In a similar study period in Hungary (1971-2010), the aver-
age rate was 6.5 per 1000.26 The prevalence, observed in our study, was
also higher than the officially reported average rate from Russia as a
whole, which declined from 6.8 to 4.7 during 2000-2010.27
We found no difference in prevalence of CVM between preterm and
term stillbirths.  According to the data of the Russian State Statistics
Service, the most common cause of stillbirth has been intrauterine
hypoxia and birth asphyxia,27 which suggests that the main explana-
tion of the higher stillbirth rate in the RF was insufficient health care
service during delivery. At the same time, live births before 28 weeks in
the RF were until 2011 defined as stillborn unless they survived the
first seven days, which inflates the stillbirth rate compared to most
other European countries.   
Interestingly, the mothers who delivered a child with CVM were ten
times more likely to have experienced a previous stillbirth. Another
study reported the same picture for Ebstein’s anomaly, and suggested
that genetic risk factors lead to defects that are non-compatible with
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Table 2. The total frequency (n) and prevalence of newborns with cardiovascular malformations among live and stillborn infants in
Monchegorsk in  6-year intervals in the period 1973-2008.   
Time period Total Live births Stillborn
N. CVM Prevalence N. CVM Prevalence N. CVM Prevalence
1973-1978 5021 14 2.8 4963 10 2.0 58 4 69.0
(1.3, 4.2) (0.8, 3.3) (1.8, 136.2)
1979-1984 6511 26 4.0 6443 22 3.4 68 4 58.8
(2.5, 5.5) (2.0, 4.8) (1.4, 116.0)
1985-1990 6508 17 2.6 6443 14 2.1 65 3 46.2
(1.4, 3.8) (1.0, 3.3) (0, 98.5)
1991-1996 3637 14 3.8 3607 13 3.6 30 1 33.3
(1.8, 5.8) (1.6, 5.6) (0, 101.5)
1997-2002 3362 9 2.7 3336 7 2.1 26 2 76.9
(0.9, 4.4) (0.5, 3.7) (0, 186.7)
2003-2008 3472 6 1.7 3445 6 1.7 27 0 0.0
(0, 3.1) (0, 3.1)
Total 28,511 86 3.0 28,237 72 2.5 274 14 51.1
(2.1, 3.9) (1.9, 3.1) (25.0, 77.6)
CVM, cardiovascular malformations; N, total number of newborns registered in the time period. Prevalence is indented per 1000 births, with 95% confidence intervals.
Table 1. Univariate comparisons of maternal and newborn characteristics between newborns with and without a cardiovascular malfor-
mation in Monchegorsk. 
Characteristics (records missing information) Newborns with CVM* Newborns without CVM* P
Mean maternal age (0.2%) 25.8 (24.4, 27.1) 25.2 (25.1, 25.2) 0.66°
Male proportion at birth (4.9%) 55% (44.2, 64.8) 51% (49.9, 52.0) 0.44#
Mean number of previous live births (6.4%) 1.4 (1.2, 1.6) 1.6 (1.6, 1.6) 0.36°
Mean number of previous stillborn (6.4%) 0.23 (0.21, 0.25) 0.02 (0.02, 0.02) <0.0001°
Mean gestational age (4.9%) 37.8 (37.4, 38.1) 39.4 (39.3, 39.5) <0.001°
Mean maternal body mass index (8.4%) 26.4 (25.7, 27.2) 27.2 (27.1, 27.2) 0.11°
Proportion with hyperglycaemia during pregnancy (6.6%) 2.4% (0.2, 8.9) 3.2% (3.0, 3.4) 0.73#
Proportion with TORCH infection during pregnancy (7.4%) 6.1% (2.3, 13.8) 3.1% (2.9, 3.3) 0.12#
Proportion observed with alcohol abuse during pregnancy (0.3%) 1.2% (0.0, 6.9) 0.5% (0.4, 0.6) 0.36#
Proportion observed as smokers during pregnancy (0.3%) 7.0% (3.0, 14.7) 2.1% (1.9, 2.2) 0.009#
Proportion of mothers suffered from endocrine disease during pregnancy (7.2%) 16.0% (9.4, 25.4) 11.7% (11.3, 12.1) 0.23#
Proportion of fathers employed at the nickel factory§ (3.5%) 49.2% (39.0, 61.0) 43.2% (42.7, 43.9) 0.10#
Proportion of mothers employed at the nickel factory§ (3.1%) 20.7% (13.3, 30.7) 20.4% (20.0, 20.9) 0.94#
Proportion of maternal occupations involving organic solvent exposure (3.1%) 3.5% (0.8, 10.2) 2.6% (2.4, 2.8) 0.59°
CVM, cardiovascular malformation. *95%  wald confidence intervals are presented in brackets; °T-test for independent samples; #Chi-square test; §the numerators include only workers in the production departments.
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life.28 This hypothesis is supported by the data in our study. When we
excluded stillbirths from the analysis, the relative likelihood of previ-
ous stillbirth among the mothers who delivered a child with CVM fell
from factor ten to factor three. 
The overall prevalence was lower than that reported in EUROCAT
and from studies in two populations in other parts of the RF.1,29
Compared to the EUROCAT averages, the prevalence was lower for all
16 forms of CVM that the EUROCAT monitors.1 The most prevalent
group of CVM was septal defects, but almost one-half of all registered
cases were recorded with an unspecified CVM diagnosis. There were
no registered cases of the severe defects: hypoplastic left heart and
coarctation of aorta. Also the prevalence of transposition of great ves-
sels (the other diagnosis that is obligatory to report in the Russian sys-
tem of surveillance) was lower than that reported from neighbouring
regions of MO and from Moscow.10,30,31 In the RF, a prenatal diagnosis
of severe CVM in regional districts may prompt a transfer of the deliv-
ery to regional centres or to Moscow for early surgical correction.
According to the data obtained from the paediatric polyclinic in
Monchegorsk, two deliveries of newborns with hypoplastic left heart
were transferred to Moscow in 2002-03. Records of births which took
place elsewhere were not filed at the local hospital and were not regis-
tered in either the KBR or the MCBR. The absence of obligatory ultra-
sound screening for fetal anomalies until 2000 could be another possi-
ble explanation low prevalence rate. 
In any birth surveillance system, both inside and outside the RF, the
true prevalence of CVM among delivered newborns is underestimated.
The estimated rates are a function of the degree of prenatal screening
and of early neonatal diagnostic measures, while the true rates also
include children who have CVM that reveals itself later in life. A study
in Bosnia-Herzegovina found that the average age for CVM diagnosis
was between the first and the second year of life, and that most of the
late diagnoses were minor CVM.2 Thus, the prevalence of small septal
and valves defects without haemodynamic problems in our study was
likely an underestimation, but the registered number of chamber
defects can be assumed to be close to the true frequency. In provincial
clinics in the RF, the lack of diagnostic tools, such as echocardiography,
at the neonatal stage of care also suggests that some forms of CVM
were under-diagnosed perinatally in most of the studied period. To
achieve a better assessment of the prevalence among newborns in
Monchegorsk we did a chart review at the local paediatric polyclinic.
The findings revealed 16 children born in 2006-2008 who had a diagno-
sis of CVM at the age of one year, while our perinatal figures based on
the MCBR included four of these (25%). Thus, the true perinatal preva-
lence was likely at least four times higher than the perinatal diagnos-
tic procedures, recording, reporting and registration in the MCBR
revealed.
Although birth-registers data provide gross underestimations of the
true prevalence of CVM and are not very comparable between systems,
the data may reveal interesting trends over time within a system, espe-
cially in terms of mortality. We observed no increase in prevalence over
time, despite the technological improvements for perinatal diagnostics
that have taken place in the RF during the last twenty years. This find-
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Table 4. Odds ratios of cardiovascular malformations for selected risk factors in Monchegorsk.
Risk factors* Unadjusted OR° Adjusted OR# 
(95% CI) (95% CI)
Maternal age less than 18 years 2.33 (0.84, 6.44) 2.11(0.77, 5.78)
Maternal age more than 39 years 1.57 (0.22, 11.37) 1.48 (0.20, 10.69)
Alcohol abuse during pregnancy 0.83 (0.10, 6.80) 0.98 (0.12, 7.90)
Smoking during pregnancy 4.34 (1.75, 10.59) 4.09 (1.75, 9.53)
Maternal occupation involving organic solvent exposure 1.41 (0.45, 4.52) 1.44 (0.44, 4.45)
TORCH infection during pregnancy 1.96 (0.79, 4.77) Not included
Endocrine disease during pregnancy 1.41 (0.78, 4.87) Not included
Father employed at the nickel factory 1.40 (0.90, 2.16) Not included
OR, odds ratios; CI, confidence intervals. *The models were tested for multi-collinearity (tolerance was about 1 for all factors); body mass index was not included in the analysis due to the number of missing values
for the newborns with CVM [12 newborns (14%)]. °We omitted in the analysis 1747 newborns (6.6%) due to missing data for one or more of the included factors, whereof 4 (4.7%) of the newborns that had CVM. #The
model included only factors without missing data for newborns with CVM. Among newborns without CVM, 1465 (5.1%) were excluded from the analysis due to missing data for one or more of the included factors. 
Table 3. The diagnosis-specific frequency, prevalence (per 1000 newborns) and distribution (%) of cardiovascular malformations among
all births, and among newborns that died perinatally in Monchegorsk (1973-2008).
Birth defect (ICD-10 code) All births* Among stillborn* Among perinatal
deaths*°
N.# % N. % N. % 
Congenital malformations of cardiac chambers and connections (Q20) 10 (0.35) 11.0 4 26.7 10 23.3
Septal defects (Q 21) 25 (0.87) 27.4 3 20.0 14 32.6
Valves defects (Q 22-23) 4 (0.14) 4.4 0 0.0 1 2.3
Other congenital malformations of heart (Q24) 45 (1.57) 49.5 6 40.0 12 27.9
Unspecified, Q 24.9 42 (1.47)
Arteries and veins anomalies (Q 25-Q27) 7 (0.25) 7.7 2 13.3 6 13.9
Other congenital malformations of circulatory system (Q28) 0 0 0 0.0 0 0.0
Total 91 (3.18)§ 100 15 100 43 100
*The figures include more than one CVM per newborn. Among stillborn one fetus had two CVM (Q 21.1, Q 25.2); among early neonatal deaths one newborn had 3 CVM (Q 21.1, Q 25.0, Q25.3) and two  had 2 CVM (21.0,
21.1 and 20.0, 24.8). °Includes CVM among stillborn and newborns who died during the first seven days. #Prevalence per 1000 newborns is presented in brackets. §The prevalence with a CVM only was 2.2 (95% C.I.: 1.6-
2.7).
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ing may suggest that the true prevalence has decreased, or that the
improved detection also led to more pregnancies being terminated in
the second trimester. Our study revealed that the perinatal mortality
among newborns with CVM has decreased in Monchegorsk (from 23
per 1000 newborns in the 1970s to 9.3 per 1000 in 2003-06), and that
the reduction mainly occurred in the early neonatal period. This find-
ing suggests that the capability of the neonatal care has improved, or
that a larger proportion of severe cases are transferred. The absence of
perinatal mortality observed among newborns with CVM in
Monchegorsk in the last time period may be explained by the small
number of newborns in that period (only half as many per year as in the
1970-80s) and transfer of women with a severe pathology of the fetus
to another clinic (one such newborn with CVM died in Moscow in
2002). 
Based on data from the Monchegorsk paediatric polyclinic, five cases
of CVM were eliminated by induced abortion after 20-25 weeks of ges-
tation in the period 2000-2006 (there were six newborns with CVM in
this time period). Data concerning miscarriages and abortions before
28 weeks are not logged in the birth registers, and therefore pregnan-
cies are not included in our prevalence estimates.
There was a tendency towards an elevated risk of CVM associated
with all the factors studied except alcohol abuse, but only an associa-
tion with smoking during pregnancy was statistically significant [OR:
4.09 (95%CI:1.75, 9.53)]. A similar adjusted OR has also been reported
by other studies.16,18 One of the studies investigated the association
between smoking and 22 different categories of congenital malforma-
tions, and found a causal association only with CVM.16
Birth registers have limitations when it comes to assessment of out-
comes that are not readily diagnosed in the perinatal period. Our find-
ings suggest that most cases of CVM were not revealed in the perinatal
period, and that some were transferred prenatally, and thereby not reg-
istered in the birth register on which our study population was based,
which constitutes a weakness. In addition, the small numbers due to
the rarity of CVM and the size of the study population lowered the pre-
cision of the estimates. Nevertheless, the limitations we have found
concerning monitoring and studies of CVM are important findings in
themselves. The study also revealed new knowledge about the distribu-
tion of different CVM diagnoses, the degree of diagnostic specification,
and the distribution and level of perinatal mortality associated with
CVM in a population in the RF.  
Conclusions
Our study was the first in the RF that estimated the perinatal preva-
lence of CVM through the use of data from population-based birth reg-
isters. The diagnosed perinatal prevalence in Monchegorsk was rela-
tively low and we did not observe a change over time (1973-2008).
Septal defects were the most prevalent of the CVM that were specified
perinatally. Mothers of newborns with CVM were ten times more likely
to have a history of previous stillbirth. One out of three infants born
alive with CVM died during the first week of life, but the perinatal sur-
vival increased over time. All newborns with chamber defects and 86%
of newborns with anomalies in arteries and veins died perinatally. The
adjusted risk of giving birth to an infant with CVM was higher among
smoking mothers than among non-smoking. 
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